10.1016j.ymthe.2016.10.003.ann

T1 CL 1127 1137 CD8 T cell
T3 Level 309 341 myeloid-derived suppressor cells
T4 Protein 1054 1058 MDSC
T5 Gene 929 943 death ligand 1
T6 Gene 1493 1508 immunotherapies
T7 Protein 20 23 GBM
T9 Gene 1318 1320 TK
T10 Protein 1091 1095 gene
T12 Protein 538 542 MDSC
T13 Protein 1471 1475 gene
T14 Protein 1054 1059 MDSCs
T15 Protein 1321 1331 Flt3L gene
T16 Biomarker 1251 1257 CTLA-4
T17 Gene 878 899 nitric oxide synthase
T18 Protein 1085 1095 Flt3L gene
T19 Protein 778 783 MDSCs
T20 Protein 742 746 gene
T21 Protein 1243 1247 PDL1
T22 Protein 901 905 iNOS
T23 Protein 956 960 CD80
T24 Level 846 851 cells
T25 Gene 606 664 immune-stimulatory herpes simplex type-I thymidine kinase 
T26 Gene 665 667 TK
T27 Protein 343 348 MDSCs
T28 Organism 24 33  patients
T29 Protein 860 866 IL-4Rα
T31 Protein 456 460 gene
T32 Protein 1388 1392 MDSC
T33 Protein 343 347 MDSC
T34 Level 807 838 tumor-infiltrating immune cells
T35 CL 1004 1027 antigen-specific T cell
T36 Protein 945 949 PDL1
T37 Condition 229 236 cancers
T38 Gene 668 705  plus Fms-like tyrosine kinase ligand
T39 Protein 778 782 MDSC
T40 Protein 238 241 GBM
T41 Protein 1513 1516 GBM